K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer CS Karapetis, S Khambata-Ford, DJ Jonker, CJ O'Callaghan, D Tu, ... New England Journal of Medicine 359 (17), 1757-1765, 2008 | 4509 | 2008 |
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer CM Ribic, DJ Sargent, MJ Moore, SN Thibodeau, AJ French, ... New England Journal of Medicine 349 (3), 247-257, 2003 | 2712 | 2003 |
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer PE Goss, JN Ingle, S Martino, NJ Robert, HB Muss, MJ Piccart, ... New England Journal of Medicine 349 (19), 1793-1802, 2003 | 2425 | 2003 |
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a … KS Albain, WE Barlow, S Shak, GN Hortobagyi, RB Livingston, IT Yeh, ... The lancet oncology 11 (1), 55-65, 2010 | 1613 | 2010 |
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA. 17 PE Goss, JN Ingle, S Martino, NJ Robert, HB Muss, MJ Piccart, ... Journal of the National Cancer Institute 97 (17), 1262-1271, 2005 | 1459 | 2005 |
Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia KR Rai, BL Peterson, FR Appelbaum, J Kolitz, L Elias, L Shepherd, ... New England Journal of Medicine 343 (24), 1750-1757, 2000 | 1426 | 2000 |
Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? S Gill, CL Loprinzi, DJ Sargent, SD Thomé, SR Alberts, DG Haller, ... Journal of clinical oncology 22 (10), 1797-1806, 2004 | 1323 | 2004 |
All-trans-Retinoic Acid in Acute Promyelocytic Leukemia MS Tallman, JW Andersen, CA Schiffer, FR Appelbaum, JH Feusner, ... New England Journal of Medicine 337 (15), 1021-1028, 1997 | 1277 | 1997 |
A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients DJ Sargent, RM Goldberg, SD Jacobson, JS Macdonald, R Labianca, ... New England Journal of Medicine 345 (15), 1091-1097, 2001 | 1181 | 2001 |
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the … M Pfreundschuh, E Kuhnt, L Trümper, A Österborg, M Trneny, L Shepherd, ... The lancet oncology 12 (11), 1013-1022, 2011 | 848 | 2011 |
Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women … MN Levine, VH Bramwell, KI Pritchard, BD Norris, LE Shepherd, ... Journal of Clinical oncology 16 (8), 2651-2658, 1998 | 756 | 1998 |
HER2 and Responsiveness of Breast Cancer to Adjuvant Chemotherapy KI Pritchard, LE Shepherd, FP O'Malley, IL Andrulis, D Tu, VH Bramwell, ... New England Journal of Medicine 354 (20), 2103-2111, 2006 | 727 | 2006 |
All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol: Presented in … MS Tallman, JW Andersen, CA Schiffer, FR Appelbaum, JH Feusner, ... Blood, The Journal of the American Society of Hematology 100 (13), 4298-4302, 2002 | 586 | 2002 |
Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated … JC Byrd, K Rai, BL Peterson, FR Appelbaum, VA Morrison, JE Kolitz, ... Blood 105 (1), 49-53, 2005 | 546 | 2005 |
Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. MJ O'Connell, JA Laurie, M Kahn, RJ Fitzgibbons Jr, C Erlichman, ... Journal of clinical oncology 16 (1), 295-300, 1998 | 529 | 1998 |
ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma RM Meyer, MK Gospodarowicz, JM Connors, RG Pearcey, WA Wells, ... New England Journal of Medicine 366 (5), 399-408, 2012 | 517 | 2012 |
Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for … M Crump, J Kuruvilla, S Couban, DA MacDonald, V Kukreti, CT Kouroukis, ... Journal of Clinical Oncology 32 (31), 3490-3496, 2014 | 455 | 2014 |
Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome: Presented in part at the meeting of the American Society of … MS Tallman, JW Andersen, CA Schiffer, FR Appelbaum, JH Feusner, ... Blood, The Journal of the American Society of Hematology 95 (1), 90-95, 2000 | 409 | 2000 |
Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin’s lymphoma: National Cancer Institute of … RM Meyer, MK Gospodarowicz, JM Connors, RG Pearcey, A Bezjak, ... Journal of Clinical Oncology 23 (21), 4634-4642, 2005 | 408 | 2005 |
Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG … EA Perez, RG Josse, KI Pritchard, JN Ingle, S Martino, BP Findlay, ... Journal of Clinical Oncology 24 (22), 3629-3635, 2006 | 372 | 2006 |